Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Equity (2016 - 2025)

Historic Return on Equity for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to 1.95%.

  • Firefly Neuroscience's Return on Equity fell 41000.0% to 1.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.95%, marking a year-over-year decrease of 41000.0%. This contributed to the annual value of 78.65% for FY2024, which is 783300.0% up from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Return on Equity is 1.95%, which was down 41000.0% from 2.64% recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Return on Equity registered a high of 5.13% during Q4 2024, and its lowest value of 163.3% during Q1 2023.
  • In the last 5 years, Firefly Neuroscience's Return on Equity had a median value of 0.1% in 2021 and averaged 10.96%.
  • As far as peak fluctuations go, Firefly Neuroscience's Return on Equity plummeted by -1632200bps in 2023, and later soared by 131400bps in 2024.
  • Firefly Neuroscience's Return on Equity (Quarter) stood at 0.1% in 2021, then tumbled by -2145bps to 2.2% in 2022, then surged by 133bps to 0.73% in 2023, then soared by 601bps to 5.13% in 2024, then plummeted by -138bps to 1.95% in 2025.
  • Its Return on Equity stands at 1.95% for Q3 2025, versus 2.64% for Q2 2025 and 8.73% for Q1 2025.